Pharvaris N.V. (PHVS)
NASDAQ: PHVS · Real-Time Price · USD
25.59
+1.57 (6.54%)
At close: Dec 19, 2025, 4:00 PM EST
26.16
+0.57 (2.23%)
After-hours: Dec 19, 2025, 7:30 PM EST
Pharvaris Market Cap
Pharvaris has a market cap or net worth of $1.66 billion as of December 19, 2025. Its market cap has increased by 53.26% in one year.
Market Cap
1.66B
Enterprise Value
1.28B
1-Year Change
53.26%
Ranking
Category
Stock Price
$25.59
Market Cap Chart
Since the IPO on February 5, 2021, Pharvaris's market cap has increased from $636.80M to $1.66B, an increase of 161.04%. That is a compound annual growth rate of 21.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 19, 2025 | 1.66B | 59.89% |
| Dec 31, 2024 | 1.04B | -28.87% |
| Dec 29, 2023 | 1.46B | 284.53% |
| Dec 30, 2022 | 380.11M | -20.27% |
| Dec 31, 2021 | 476.72M | -25.14% |
| Feb 5, 2021 | 636.80M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 959.35B |
| Johnson & Johnson | 497.21B |
| AbbVie | 400.88B |
| UnitedHealth Group | 296.59B |
| AstraZeneca | 283.55B |
| Novartis AG | 261.76B |
| Merck & Co. | 250.91B |
| Abbott Laboratories | 218.14B |